GGrantIndex
Sort

40,608 grants matching prostate cancer

Integration of Omic Data to Estimate Mediation or Latent Structures

$360,215
David V Conti · University Of Southern California · P01 · FY2025 · CA

Targeting Cell Cycle Alterations to Improve Treatment for Advanced Prostate Cancer

$360,198
Karen E Knudsen · Thomas Jefferson University · R01 · FY2018 · CA

Ornithine Aminotransferase Inactivation, a New Approach for Treatment of Cancers

$360,196
Richard B Silverman · Northwestern University · R01 · FY2023 · CA

SOX9 in prostate cancer development and progression

$360,188
Xin Yuan · Beth Israel Deaconess Medical Center · R01 · FY2010 · DK

Molecular mechanisms specific to ETS transcription factors that drive oncogenesis

$360,124
Peter Celestine Hollenhorst · Indiana University Indianapolis · R01 · FY2018 · CA

Therapeutic Efficacy of Flaxseed in the Treatment of Ovarian Cancer

$360,113
Dale B Hales · Southern Illinois University Carbondale · R01 · FY2012 · AT

Dose-Response in Radionuclide Therapy

$360,084
George Sgouros · Johns Hopkins University · R01 · FY2014 · CA

Developing Quality Indicators for Advanced Cancer Care

$360,081
Jane C. Weeks · Dana-Farber Cancer Inst · R01 · FY2007 · CA

Omega-3 PUFA-gene interaction in prostate cancer

$360,081
Yong Q Chen · Wake Forest University Health Sciences · R01 · FY2016 · CA

Omega-3 PUFA-gene interaction in prostate cancer

$360,081
Yong Q Chen · Wake Forest University Health Sciences · R01 · FY2015 · CA

Elucidating the Role of Trop2 in Prostate Cancer

$360,059
Tanya I Stoyanova · University Of California Los Angeles · R37 · FY2025 · CA

Tumor and Circulating Markers as Links Between Obesity and Lethal Prostate Cance

$360,051
Lorelei Mucci · Dana-Farber Cancer Inst · P50 · FY2017 · CA

Transmembrane Proteins Involved in Human Tumor Expansion

$360,050
James P Quigley · Scripps Research Institute, The · R01 · FY2015 · CA

Regulation and Function of SUMO Protein Modification

$360,037
Michael J. Matunis · Johns Hopkins University · R01 · FY2017 · GM

CYTOGENETICS AND BIOCHEMISTRY OF PROSTATE CANCER

$360,009
Case Western Reserve University · R01 · FY2000 · CA

NOVEL PTEN REGULATORY PATHWAY FOR PROSTATE CANCER THERAPY

$360,000
The Univeristy Of Texas M.D. Anderson Cancer Center · · FY2015 · Department of Defense

UNDERSTANDING AND TARGETING TUMOR MICROENVIRONMENT IN PROSTATE CANCER TO INHIBIT TUMOR PROGRESSION AND CASTRATION RESISTANCE

$360,000
The Univeristy Of Texas M.D. Anderson Cancer Center · · FY2014 · Department of Defense

TARGETING MEK5 ENHANCES RADIOSENSITIVITY OF HUMAN PROSTATE CANCER AND IMPAIRS TUMOR-ASSOCIATED ANGIOGENESIS

$360,000
The Trustees Of Columbia University In The City Of New York · · FY2015 · Department of Defense

Project 2: Re-directing the Sensitivity of Metastatic Castration-Resistant Prostate Cancer to Immunotherapy

$360,000
Jennifer D Wu · Northwestern University At Chicago · P50 · FY2025 · CA

A Health IT based Psychoeducational Intervention for African American Prostate Cancer

$359,947
Brian M. Rivers · Morehouse School Of Medicine · R01 · FY2019 · MD

Molecular biomarkers of selenium chemoprevention

$359,933
Roswell Park Cancer Institute Corp · R01 · FY2005 · CA

PRECLINICAL PROSTATE CANCER CHEMOPREVENTION STUDIES

$359,911
New York University School Of Medicine · R01 · FY2000 · CA

Genetic Variation in Cancer Risk and Outcomes in African Americans

$359,901
Felicity Harper · Wayne State University · P01 · FY2024 · CA

Functional Significance of Prostate Cancer risk-SNPs

$359,898
Stephen Norman Thibodeau · Mayo Clinic Rochester · R01 · FY2015 · CA

BIOMARKERS FOR EARLY DETECTION OF CLINICALLY RELEVANT PROSTATE CANCER: A MULTI-INSTITUTIONAL VALIDATION TRIAL

$359,817
The Cleveland Clinic Foundation · · FY2014 · Department of the Army